Novel rechargeable nano-calcium phosphate and nano-calcium fluoride resin cements.


Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 11 05 2022
revised: 12 09 2022
accepted: 14 09 2022
pubmed: 3 10 2022
medline: 26 10 2022
entrez: 2 10 2022
Statut: ppublish

Résumé

In most clinical circumstances, secondary caries at the margin of fixed dental restorations leads to restoration failure and replacement. Accordingly, the objectives of this study were to: (1) develop a novel rechargeable nano-calcium phosphate (NACP) and nano-calcium fluoride (nCaF The cement matrix consisted of pyromellitic glycerol dimethacrylate (PMGDM), ethoxylated bisphenol-A-dimethacrylate (EBPADMA) was denoted PEHB. Four cements were fabricated: (1) PEHB+0%NACP+0%nCaF Adding 25% NACP, 25% nCaF The resin cement group with both 12.5% NACP and 12.5% nCaF The ability of this novel resin-based cement to release, recharge, and re-release Ca, P, and F ions could be one of the keys to lengthening the survivability of fixed dental restorations. These features could help to reduce the onset of secondary caries by enhancing the remineralization and preventing the demineralization of tooth structures.

Identifiants

pubmed: 36184005
pii: S0300-5712(22)00367-0
doi: 10.1016/j.jdent.2022.104312
pii:
doi:

Substances chimiques

Resin Cements 0
Fluorides Q80VPU408O
Calcium Fluoride O3B55K4YKI
Glycerol PDC6A3C0OX
calcium phosphate 97Z1WI3NDX
Calcium Phosphates 0
Methacrylates 0
Dental Cements 0
Dental Materials 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104312

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Rashed AlSahafi (R)

PhD Program in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Department of Restorative Dental Sciences, Umm Al-Qura University, College of Dentistry, Makkah 24211, Saudi Arabia.

Heba Mitwalli (H)

Department of Restorative Dental Sciences, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia.

Abdullah Alhussein (A)

PhD Program in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Department of Restorative Dental Sciences, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia.

Abdulrahman A Balhaddad (AA)

Department of Restorative Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

Theeb A Alquria (TA)

PhD Program in Dental Biomedical Sciences, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Department of Restorative Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.

Mary Anne S Melo (MAS)

Division of Operative Dentistry, Department of General Dentistry, University of Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.

Christopher D Lynch (CD)

Restorative Dentistry, University Dental School and Hospital, University College Cork, Wilton, Cork, Ireland.

Thomas W Oates (TW)

Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America.

Ke Zhang (K)

School of Stomatology, Capital Medical University, Beijing, China. Electronic address: tuzizhangke@163.com.

Hockin H K Xu (HHK)

Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America; Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, 21201, United States of America. Electronic address: HXu2@umaryland.edu.

Michael D Weir (MD)

Biomaterials & Tissue Engineering Division, Dept. of Advanced Oral Sciences and Therapeutics, University Maryland School of Dentistry, Baltimore, MD 21201, United States of America. Electronic address: michael.weir@umaryland.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH